CRISPR Therapeutics and collaborators at the University of Florida awarded Target ALS
 

CRISPR Therapeutics and collaborators at the University of Florida awarded Target ALS Grant to develop CRISPR/Cas9-based approaches for ALS

CRISPR Therapeutics and collaborators at the University of Florida awarded Target ALS Grant to develop CRISPR/Cas9-based approaches for ALS | P&T Community

Target ALS Foundation, award grant to CRISPR Therapeutics AG (NASDAQ:CRSP) to support
 

Target ALS Foundation, award grant to CRISPR Therapeutics AG (NASDAQ:CRSP) to support CRISPR/Cas9-based therapeutic approaches

Target ALS Foundation, award grant to CRISPR Therapeutics AG (NASDAQ:CRSP) to support CRISPR/Cas9-based therapeutic approaches | Benchmark Monitor

CRISPR Therapeutics and collaborators at the University of Florida awarded Target ALS
 

CRISPR Therapeutics and collaborators at the University of Florida awarded Target ALS Grant to develop CRISPR/Cas9-based approaches for ALS

CRISPR Therapeutics and collaborators at the University of Florida awarded Target ALS Grant to develop CRISPR/Cas9-based approaches for ALS - News Press Release | PharmiWeb.com

NOTE: CRISPR is very recent biological development . . . and widely seen as Nobel prize candidate:

CRISPR loses Nobel to tiny machines
CRISPR loses Nobel to tiny machines | TechCrunch

Eric Lander talks CRISPR and the infamous Nobel ‘rule of three’
Eric Lander talks CRISPR and the infamous Nobel ‘rule of three’ - The Washington Post

they are already interested in amazing Amyotrophic Lateral Sclerosis applications?!

Crispr
 

CRISPR

CRISPR - Wikipedia